|
EP3814349A1
|
|
Hedgehog pathway inhibition for treatment of high-risk basal cell carcinoma or high-risk basal cell carcinoma nevus syndrome
|
|
US2017182070A1
|
|
Controlled Release Doxycycline
|
|
AU2016210639A1
|
|
Diphosphonate solutions
|
|
US2016101060A1
|
|
Controlled release doxycycline
|
|
US9295652B1
|
|
Controlled release doxycycline
|
|
CN112043829A
|
|
Treatment and prognostic monitoring of proliferative disorders using HEDGEHOG pathway inhibitors
|
|
MX2015000179A
|
|
Itraconazole compositions and dosage forms, and methods of using the same.
|
|
AU2012200819A1
|
|
Diphosphonate solutions
|
|
AU2012211036A1
|
|
Extended release acetaminophen liquid pharmaceutical compositions
|
|
AU2009212953A1
|
|
Compositions and methods for delivery of biologically active agents
|
|
AU2007203056A1
|
|
Diphosphonate solutions
|
|
AU2005299253A1
|
|
Improved tabletting process
|
|
EP1667656A1
|
|
Compositions and methods for delivery of biologically active agents
|
|
AU2003213876A1
|
|
An improved modified release preparation
|
